Transforming IBD Care

Gain a multidisciplinary perspective on treating inflammatory bowel diseases (IBD). Join health care professionals and researchers at the Crohn’s & Colitis Congress® for the premier conference on IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon. See you there on February 7–9, 2019, in Las Vegas.

Dates to Remember

Early Bird Deadline: 8/29/2018

Standard Registration Deadline: 12/12/2018

Abstract Submission Opens: 8/1/2018

Submission Deadline: 10/24/2018

Notifications: 12/7/2018


Crohn’s & Colitis Congress Chairs

Brent Polk, MD, AGAF

Organizing Committee Chair
Children’s Hospital of Los Angeles
University of Southern California

Maria T. Abreu, MD, AGAF

Organizing Committee Co-Chair
University of Miami Health System

David T. Rubin, MD, AGAF

Organizing Committee Co-Chair
University of Chicago

Supporting Organizations

The 2018 Crohn’s & Colitis Congress was supported by educational grants from:
The 2019 Crohn’s & Colitis Congress is endorsed by:

Building on the success of this year’s inaugural Crohn’s & Colitis Congress™, the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are pleased to announce the second annual Crohn’s & Colitis Congress. Be sure to save the date.

February 7-9, 2019 at the Bellagio in Las Vegas

Gain a multidisciplinary perspective on treating IBD. Join IBD health care professionals to network, learn from each other, and collaborate in transforming IBD patient care.

By bringing all audiences together to learn from each other, the Congress embodies how IBD research and patient care needs to be approached – it is not “one-size-fits-all” and it requires collaboration from a variety of health practitioners.

Be sure to visit this website in the future for more details. Registration will open on June 27, 2018

If you attended the 2018 Crohn’s & Colitis Congress, you can continue to use the mobile app after the meeting to view session presentations (that presenters agreed to publish), abstracts and more.

To claim CME for the Congress, please complete the CME Request Form. Your CME certificate will be emailed to you within a week of completing the form.


The Crohn's & Colitis Congress is supported by educational grants from AbbVie Inc., Celgene Corporation, Gilead Sciences, Inc., Merck & Co., Inc., Nestlé Health Science, Pfizer, Salix Pharmaceuticals, Shire Plc. and Takeda Pharmaceuticals U.S.A., Inc.

Endorsed By: